Sanofi SA (NASDAQ:GCVRZ)

0.88
Data as of 4:00pm ET
 +0.02 / +2.33%
Today’s Change
0.30
Today|||52-Week Range
1.06
+158.82%
Year-to-Date
Regeneron & Sanofi Present Positive Data on PCSK9 Drug - Analyst Blog
5:07pm / Zacks.com
7 Biggest Health Problems Americans Face
Nov 16 / MotleyFool.com
Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog
5:07pm / Zacks.com
Position Updates
Nov 15 / StockTwits
3 Stocks Pushing The Health Care Sector Lower
3:41pm / TheStreet.com
Amicus Drug Improves Marker of Heart Health in Fabry Patients
Nov 15 / TheStreet.com
GlaxoSmithKline vs. Sanofi: Which Is The Better Dividend Stock?
11:16am / MotleyFool.com
Isis/AstraZeneca Expand Antisense Technology Collaboration - Analyst Blog
Nov 14 / Zacks.com
Biotech's 3 Most Influential CEOs
10:21am / MotleyFool.com
Healthcare's Top Dividend Paying Stocks
Nov 13 / MotleyFool.com
European Stocks Decline Amid Weak Eurozone, China Manufacturing Reports
6:11am / TheStreet.com
Regeneron/Sanofi Announce Positive Dupilumab Study Data - Analyst Blog
Nov 12 / Zacks.com
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews
Nov 19 / Zacks.com
PDL BioPharma's Q3 Earnings and Revenues Increase Y/Y - Analyst Blog
Nov 11 / Zacks.com
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
Nov 19 / Zacks.com
3 Crashing Stocks: Is 1 a Buy?
Nov 09 / MotleyFool.com
Submarine Basket Mid-week Update
Nov 19 / StockTwits
Isis Pharmaceuticals Inc. Strikes Out on Its Own
Nov 07 / MotleyFool.com
Covance (CVD) Sellout Decision to LabCorp: A Strategic Fit? - Analyst Blog
Nov 18 / Zacks.com
VIVUS Posts Narrower-than-Expected Q3 Loss, Revenues Up - Analyst Blog
Nov 06 / Zacks.com
Alnylam Reports Positive Initial Phase II Data on Revusiran - Analyst Blog
Nov 17 / Zacks.com
All Eyes on ISIS Pharmaceuticals, Inc.'s Pipeline
Nov 06 / MotleyFool.com
Sanofi's Lemtrada Gets U.S. Approval, Carries Boxed Warning - Analyst Blog
Nov 17 / Zacks.com
Stocks: 6 things to know before the open
Oct 29 / CNNMoney.com
November Options Expiration – The Plan
Nov 16 / StockTwits
 

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.